CAS 55327-43-0: 4-Imidazolidinone, 3-(4-chlorophenyl)-2-thioxo-
Description:4-Imidazolidinone, 3-(4-chlorophenyl)-2-thioxo- is a chemical compound characterized by its imidazolidinone core structure, which features a five-membered ring containing two nitrogen atoms. The presence of a thioxo group (a sulfur atom double-bonded to a carbon atom) at the 2-position contributes to its reactivity and potential biological activity. The 3-position is substituted with a 4-chlorophenyl group, which can influence the compound's lipophilicity and interaction with biological targets. This compound may exhibit various pharmacological properties, making it of interest in medicinal chemistry. Its molecular structure suggests potential applications in drug development, particularly in the design of agents targeting specific biological pathways. Additionally, the presence of the chlorophenyl moiety may enhance its binding affinity to certain receptors or enzymes. As with many chemical substances, safety and handling precautions should be observed, as the specific toxicity and environmental impact of this compound would need to be evaluated through further research and testing.
Formula:C9H7ClN2OS
Brand | Product data | Purity | Price range | Estimated delivery |
---|---|---|---|---|
![]() | 3-(4-chlorophenyl)-2-sulfanylideneimidazolidin-4-one REF: 10-F650878CAS: 55327-43-0 | 97% | - - - | Discontinued product |
![]() | 1-(4-Chlorophenyl)-2-sulfanyl-4,5-dihydro-1H-imidazol-5-one REF: 3D-FCA32743CAS: 55327-43-0 | Min. 95% | - - - | Discontinued product |

3-(4-chlorophenyl)-2-sulfanylideneimidazolidin-4-one
Ref: 10-F650878
1g | Discontinued | Request information | |
2.5g | Discontinued | Request information | |
50mg | Discontinued | Request information | |
100mg | Discontinued | Request information | |
250mg | Discontinued | Request information | |
500mg | Discontinued | Request information |

1-(4-Chlorophenyl)-2-sulfanyl-4,5-dihydro-1H-imidazol-5-one
Ref: 3D-FCA32743
1g | Discontinued | Request information | |
100mg | Discontinued | Request information |